Chenghui Li
Concepts (225)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 4 | 2024 | 398 | 2.580 |
Why?
| Poverty Areas | 3 | 2025 | 42 | 2.040 |
Why?
| Healthcare Disparities | 3 | 2024 | 299 | 2.030 |
Why?
| Breast Neoplasms | 7 | 2024 | 1212 | 1.700 |
Why?
| Insurance Coverage | 4 | 2024 | 115 | 1.540 |
Why?
| Colorectal Neoplasms | 2 | 2025 | 294 | 1.430 |
Why?
| Chronic Pain | 8 | 2024 | 177 | 1.420 |
Why?
| Medicare | 7 | 2024 | 274 | 1.390 |
Why?
| Medicaid | 6 | 2023 | 264 | 1.350 |
Why?
| Poverty | 3 | 2025 | 219 | 1.190 |
Why?
| Aged | 29 | 2025 | 10121 | 1.180 |
Why?
| United States | 25 | 2024 | 5192 | 1.160 |
Why?
| Analgesics, Opioid | 11 | 2024 | 590 | 1.140 |
Why?
| Humans | 51 | 2025 | 52483 | 0.890 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2024 | 53 | 0.870 |
Why?
| Retrospective Studies | 26 | 2024 | 6607 | 0.860 |
Why?
| Patient Care | 4 | 2024 | 57 | 0.830 |
Why?
| Medication Adherence | 1 | 2024 | 133 | 0.810 |
Why?
| Prostate | 4 | 2024 | 116 | 0.800 |
Why?
| Developmental Disabilities | 1 | 2023 | 122 | 0.790 |
Why?
| Health Status Disparities | 1 | 2025 | 215 | 0.790 |
Why?
| Conduct Disorder | 1 | 2022 | 9 | 0.780 |
Why?
| Intellectual Disability | 1 | 2023 | 127 | 0.770 |
Why?
| Back Pain | 2 | 2021 | 39 | 0.770 |
Why?
| Pharmacy | 1 | 2023 | 55 | 0.760 |
Why?
| Middle Aged | 25 | 2025 | 13028 | 0.760 |
Why?
| Female | 35 | 2025 | 28171 | 0.760 |
Why?
| Adult | 26 | 2024 | 14161 | 0.740 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 170 | 0.730 |
Why?
| Male | 30 | 2025 | 26761 | 0.730 |
Why?
| Students, Pharmacy | 1 | 2023 | 123 | 0.720 |
Why?
| SEER Program | 5 | 2024 | 103 | 0.720 |
Why?
| Medical Records Systems, Computerized | 2 | 2011 | 38 | 0.700 |
Why?
| Mental Disorders | 3 | 2015 | 428 | 0.690 |
Why?
| Education, Pharmacy | 1 | 2023 | 150 | 0.690 |
Why?
| Premature Birth | 1 | 2022 | 153 | 0.670 |
Why?
| Arkansas | 8 | 2024 | 2028 | 0.650 |
Why?
| Brain Neoplasms | 1 | 2023 | 291 | 0.650 |
Why?
| Databases, Factual | 5 | 2024 | 706 | 0.580 |
Why?
| Adolescent | 13 | 2024 | 6739 | 0.570 |
Why?
| Osteoarthritis | 1 | 2018 | 61 | 0.570 |
Why?
| Lung Neoplasms | 1 | 2023 | 636 | 0.540 |
Why?
| Registries | 3 | 2025 | 581 | 0.530 |
Why?
| Young Adult | 12 | 2024 | 4329 | 0.530 |
Why?
| Antipsychotic Agents | 3 | 2014 | 235 | 0.510 |
Why?
| Quality of Life | 2 | 2018 | 879 | 0.480 |
Why?
| Bupropion | 1 | 2015 | 34 | 0.480 |
Why?
| Pneumonia, Pneumococcal | 1 | 2015 | 11 | 0.470 |
Why?
| Pneumococcal Vaccines | 1 | 2015 | 13 | 0.470 |
Why?
| Smoking Cessation | 2 | 2015 | 315 | 0.470 |
Why?
| Community-Acquired Infections | 1 | 2015 | 45 | 0.460 |
Why?
| Influenza Vaccines | 1 | 2015 | 35 | 0.450 |
Why?
| Drug Overdose | 4 | 2022 | 163 | 0.440 |
Why?
| Alcoholism | 3 | 2021 | 239 | 0.440 |
Why?
| Socioeconomic Factors | 3 | 2024 | 610 | 0.420 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 1678 | 0.420 |
Why?
| Atrial Fibrillation | 2 | 2015 | 200 | 0.410 |
Why?
| Tramadol | 2 | 2024 | 30 | 0.400 |
Why?
| Drug Prescriptions | 2 | 2021 | 102 | 0.400 |
Why?
| Aged, 80 and over | 7 | 2023 | 3392 | 0.400 |
Why?
| Neuralgia | 2 | 2023 | 43 | 0.390 |
Why?
| Tobacco Use Cessation | 1 | 2012 | 10 | 0.390 |
Why?
| Smoking | 2 | 2015 | 520 | 0.390 |
Why?
| Polypharmacy | 1 | 2011 | 15 | 0.380 |
Why?
| Neoplasms | 1 | 2022 | 1325 | 0.380 |
Why?
| Practice Management, Medical | 1 | 2011 | 10 | 0.370 |
Why?
| Minority Groups | 2 | 2023 | 135 | 0.360 |
Why?
| Anti-Arrhythmia Agents | 1 | 2011 | 81 | 0.360 |
Why?
| Insurance, Health | 2 | 2024 | 131 | 0.360 |
Why?
| Adrenergic beta-Antagonists | 1 | 2011 | 110 | 0.360 |
Why?
| Emergency Service, Hospital | 2 | 2016 | 522 | 0.350 |
Why?
| Medical Informatics | 1 | 2011 | 57 | 0.350 |
Why?
| Attitude to Computers | 1 | 2010 | 17 | 0.340 |
Why?
| Medically Underserved Area | 1 | 2010 | 46 | 0.330 |
Why?
| Analgesics, Non-Narcotic | 1 | 2011 | 117 | 0.320 |
Why?
| Insurance Claim Review | 2 | 2024 | 40 | 0.320 |
Why?
| Opioid-Related Disorders | 3 | 2022 | 400 | 0.300 |
Why?
| Child | 5 | 2024 | 7248 | 0.300 |
Why?
| Acetaminophen | 1 | 2011 | 279 | 0.290 |
Why?
| Health Care Surveys | 3 | 2011 | 177 | 0.260 |
Why?
| Attitude of Health Personnel | 1 | 2010 | 360 | 0.260 |
Why?
| Health Services Accessibility | 2 | 2022 | 436 | 0.260 |
Why?
| Propensity Score | 4 | 2022 | 154 | 0.260 |
Why?
| Rural Population | 2 | 2025 | 577 | 0.250 |
Why?
| Health Care Costs | 2 | 2024 | 174 | 0.250 |
Why?
| Survival Analysis | 2 | 2025 | 673 | 0.250 |
Why?
| Odds Ratio | 4 | 2020 | 558 | 0.240 |
Why?
| Substance-Related Disorders | 2 | 2021 | 609 | 0.230 |
Why?
| Receptors, Progesterone | 1 | 2024 | 66 | 0.220 |
Why?
| Urban Population | 1 | 2025 | 162 | 0.220 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2021 | 52 | 0.220 |
Why?
| Child, Preschool | 3 | 2024 | 4076 | 0.220 |
Why?
| Proportional Hazards Models | 1 | 2025 | 443 | 0.220 |
Why?
| Ileus | 1 | 2023 | 14 | 0.220 |
Why?
| Receptors, Estrogen | 1 | 2024 | 131 | 0.210 |
Why?
| Cohort Studies | 6 | 2022 | 1542 | 0.210 |
Why?
| Obesity | 1 | 2011 | 1162 | 0.210 |
Why?
| Confidence Intervals | 3 | 2013 | 158 | 0.200 |
Why?
| Activities of Daily Living | 1 | 2023 | 182 | 0.200 |
Why?
| Radiation Injuries | 1 | 2023 | 110 | 0.190 |
Why?
| Colonic Neoplasms | 1 | 2023 | 163 | 0.190 |
Why?
| Prescriptions | 1 | 2021 | 11 | 0.190 |
Why?
| Health Expenditures | 1 | 2022 | 72 | 0.190 |
Why?
| Neck Pain | 1 | 2021 | 10 | 0.180 |
Why?
| Respiratory Insufficiency | 1 | 2023 | 120 | 0.180 |
Why?
| Arthralgia | 1 | 2021 | 44 | 0.180 |
Why?
| Professional-Patient Relations | 1 | 2021 | 47 | 0.180 |
Why?
| Heart Diseases | 1 | 2023 | 216 | 0.170 |
Why?
| Infant | 2 | 2024 | 3733 | 0.170 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 358 | 0.170 |
Why?
| Hypertension | 2 | 2018 | 565 | 0.170 |
Why?
| Neoplasm Micrometastasis | 1 | 2020 | 7 | 0.170 |
Why?
| Veterans | 5 | 2021 | 583 | 0.170 |
Why?
| Curriculum | 1 | 2023 | 398 | 0.160 |
Why?
| Hawaii | 1 | 2020 | 117 | 0.160 |
Why?
| Anxiety | 1 | 2022 | 300 | 0.160 |
Why?
| Preventive Health Services | 1 | 2020 | 52 | 0.160 |
Why?
| Multivariate Analysis | 2 | 2011 | 591 | 0.160 |
Why?
| Arterial Pressure | 1 | 2018 | 45 | 0.150 |
Why?
| Practice Guidelines as Topic | 3 | 2016 | 488 | 0.150 |
Why?
| Sleep Deprivation | 1 | 2018 | 19 | 0.150 |
Why?
| Vancomycin | 1 | 2018 | 85 | 0.140 |
Why?
| Vasoconstrictor Agents | 1 | 2018 | 82 | 0.140 |
Why?
| Logistic Models | 2 | 2011 | 925 | 0.140 |
Why?
| Shock, Septic | 1 | 2018 | 82 | 0.140 |
Why?
| Metabolic Diseases | 1 | 2018 | 46 | 0.140 |
Why?
| Risk Factors | 4 | 2018 | 3889 | 0.140 |
Why?
| Depression | 1 | 2022 | 600 | 0.130 |
Why?
| Ganciclovir | 1 | 2016 | 24 | 0.130 |
Why?
| Cytomegalovirus | 1 | 2016 | 29 | 0.130 |
Why?
| Cytomegalovirus Infections | 1 | 2016 | 34 | 0.130 |
Why?
| Antibiotic Prophylaxis | 1 | 2016 | 61 | 0.130 |
Why?
| Inappropriate Prescribing | 1 | 2016 | 23 | 0.120 |
Why?
| Drug Therapy, Combination | 2 | 2018 | 395 | 0.120 |
Why?
| Nicotinic Agonists | 1 | 2015 | 56 | 0.120 |
Why?
| Decision Support Techniques | 1 | 2015 | 70 | 0.120 |
Why?
| Antiviral Agents | 1 | 2016 | 178 | 0.120 |
Why?
| Hospitals, Veterans | 1 | 2015 | 110 | 0.110 |
Why?
| Length of Stay | 2 | 2015 | 663 | 0.110 |
Why?
| Acute Kidney Injury | 1 | 2018 | 319 | 0.110 |
Why?
| Kidney Transplantation | 1 | 2016 | 192 | 0.110 |
Why?
| Follow-Up Studies | 4 | 2024 | 2279 | 0.110 |
Why?
| Hyperglycemia | 1 | 2014 | 88 | 0.110 |
Why?
| Venous Thromboembolism | 1 | 2015 | 77 | 0.110 |
Why?
| Hydrocodone | 2 | 2024 | 20 | 0.100 |
Why?
| Oxycodone | 2 | 2024 | 26 | 0.100 |
Why?
| Cholesterol, LDL | 1 | 2013 | 43 | 0.100 |
Why?
| Anticoagulants | 1 | 2015 | 270 | 0.100 |
Why?
| Hospital Mortality | 1 | 2015 | 435 | 0.100 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 807 | 0.100 |
Why?
| Cardiovascular Diseases | 1 | 2018 | 490 | 0.100 |
Why?
| Drug Substitution | 1 | 2011 | 10 | 0.090 |
Why?
| Office Visits | 1 | 2011 | 45 | 0.090 |
Why?
| Hyperlipidemias | 1 | 2011 | 52 | 0.090 |
Why?
| Severity of Illness Index | 1 | 2015 | 1026 | 0.090 |
Why?
| Hospitalization | 1 | 2016 | 736 | 0.090 |
Why?
| Linear Models | 1 | 2011 | 287 | 0.090 |
Why?
| Choice Behavior | 1 | 2011 | 83 | 0.090 |
Why?
| Regression Analysis | 1 | 2011 | 401 | 0.090 |
Why?
| Body Weight | 1 | 2013 | 523 | 0.090 |
Why?
| Physicians' Offices | 1 | 2010 | 5 | 0.080 |
Why?
| Information Systems | 1 | 2010 | 27 | 0.080 |
Why?
| Weight Gain | 1 | 2011 | 240 | 0.080 |
Why?
| Blood Glucose | 1 | 2013 | 473 | 0.080 |
Why?
| Ambulatory Care | 1 | 2011 | 239 | 0.080 |
Why?
| Statistics, Nonparametric | 1 | 2010 | 192 | 0.080 |
Why?
| Patients | 1 | 2010 | 51 | 0.080 |
Why?
| Case-Control Studies | 2 | 2023 | 1201 | 0.080 |
Why?
| Comorbidity | 1 | 2011 | 625 | 0.080 |
Why?
| Time Factors | 2 | 2016 | 2968 | 0.080 |
Why?
| Models, Statistical | 1 | 2010 | 230 | 0.080 |
Why?
| Pain Measurement | 2 | 2021 | 256 | 0.080 |
Why?
| Guideline Adherence | 2 | 2023 | 138 | 0.070 |
Why?
| Diabetes Mellitus | 1 | 2011 | 316 | 0.070 |
Why?
| Age Factors | 1 | 2011 | 1132 | 0.070 |
Why?
| United States Department of Veterans Affairs | 2 | 2020 | 293 | 0.060 |
Why?
| Physicians | 2 | 2021 | 241 | 0.060 |
Why?
| Incidence | 2 | 2018 | 1062 | 0.060 |
Why?
| Anastomotic Leak | 1 | 2023 | 11 | 0.050 |
Why?
| Colectomy | 1 | 2023 | 35 | 0.050 |
Why?
| Biological Factors | 1 | 2023 | 12 | 0.050 |
Why?
| Prevalence | 2 | 2018 | 1006 | 0.050 |
Why?
| Heart Atria | 1 | 2023 | 63 | 0.050 |
Why?
| Analgesics | 1 | 2023 | 107 | 0.050 |
Why?
| Accidents | 1 | 2021 | 21 | 0.050 |
Why?
| Patient Readmission | 1 | 2023 | 246 | 0.050 |
Why?
| Heart | 1 | 2023 | 345 | 0.040 |
Why?
| Pain | 1 | 2022 | 362 | 0.040 |
Why?
| Radiotherapy, Adjuvant | 1 | 2020 | 63 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2023 | 1229 | 0.040 |
Why?
| Needs Assessment | 1 | 2020 | 140 | 0.040 |
Why?
| Mastectomy | 1 | 2020 | 143 | 0.040 |
Why?
| Delivery of Health Care | 1 | 2021 | 323 | 0.040 |
Why?
| Depressive Disorder, Major | 1 | 2020 | 148 | 0.040 |
Why?
| Goals | 1 | 2018 | 43 | 0.040 |
Why?
| Quality of Health Care | 1 | 2020 | 187 | 0.040 |
Why?
| Rats | 1 | 2023 | 3220 | 0.030 |
Why?
| Health Surveys | 1 | 2018 | 238 | 0.030 |
Why?
| Serologic Tests | 1 | 2016 | 25 | 0.030 |
Why?
| Opportunistic Infections | 1 | 2016 | 56 | 0.030 |
Why?
| Postoperative Complications | 1 | 2023 | 1068 | 0.030 |
Why?
| Survival Rate | 1 | 2018 | 945 | 0.030 |
Why?
| Critical Illness | 1 | 2018 | 317 | 0.030 |
Why?
| Graft Rejection | 1 | 2016 | 177 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2018 | 747 | 0.030 |
Why?
| Geriatrics | 1 | 2016 | 47 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2015 | 95 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 200 | 0.030 |
Why?
| Cost of Illness | 1 | 2015 | 121 | 0.030 |
Why?
| China | 1 | 2014 | 134 | 0.030 |
Why?
| Venous Thrombosis | 1 | 2015 | 90 | 0.030 |
Why?
| Tobacco Smoke Pollution | 1 | 2014 | 56 | 0.030 |
Why?
| Pulmonary Embolism | 1 | 2015 | 86 | 0.030 |
Why?
| Time-to-Treatment | 1 | 2014 | 78 | 0.030 |
Why?
| Interviews as Topic | 1 | 2014 | 275 | 0.030 |
Why?
| Hospitals | 1 | 2015 | 182 | 0.030 |
Why?
| Focus Groups | 1 | 2014 | 196 | 0.030 |
Why?
| Disease Management | 1 | 2014 | 188 | 0.030 |
Why?
| Recurrence | 1 | 2015 | 672 | 0.030 |
Why?
| Drug Monitoring | 1 | 2013 | 83 | 0.020 |
Why?
| Motivation | 1 | 2014 | 282 | 0.020 |
Why?
| Qualitative Research | 1 | 2014 | 364 | 0.020 |
Why?
| Risk Assessment | 1 | 2015 | 1327 | 0.020 |
Why?
| Animals | 1 | 2023 | 13505 | 0.020 |
Why?
| Treatment Outcome | 1 | 2016 | 5422 | 0.020 |
Why?
|
|
Li's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|